Green Thumb Industries Inc (GTBIF)

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare.

The U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.

Congress appears set to end the record-long government shutdown, but a controversial provision tucked into the spending bill is sparking alarm across the hemp and cannabis industry.

Tilray Brands (NASDAQ: TLRY) has once again found itself at the epicenter of market volatility, with its stock experiencing a significant dip this past week, closing near $1.34 USD as of early November 2025. This downturn comes amidst a complex tapestry of mixed signals, leaving investors and analysts grappling

Ascend Wellness Holdings (CSE: AAWH.U, OTCQX: AAWH), once a promising standout in the burgeoning cannabis sector, is increasingly finding itself battling for relevance as the broader market matures and faces significant headwinds. Despite a notable stock rally earlier in 2025, the multi-state operator (MSO) has seen its financial fundamentals

Green Thumb looks like a rare opportunity to grow your marijuana profits.

The industry got a stark reminder that the wheels of legalization are turning very slowly.

Green Thumb (GTI) stood out in Q1 2025 as the only Tier 1 cannabis company to post growth, per a new report from Zuanic & Associates.

Doug Kass says most cannabis stocks are ‘walking dead' — but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors.

This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.

GTI, Verano, Cannabist, MariMed, Cronos and IIPR reported Q1 2025 earnings. Here's what happened.

Florida's new ballot law targets cannabis legalization efforts and sparks a federal lawsuit. Major backers include Trulieve, Verano, Curaleaf.